Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX

5.40

+0.51 (+10.43%)

4:00:00 PM EDT: $5.44 +0.04 (+0.74%)

Market Cap (Intraday)	878.71M
Current PE	82.61
Forward PE	8.71
2yr Forward PE	7.61

See more stats

Estimates Current Quarter

Revenue	$504.81 Million
Adjusted EPS	$0.13

See more estimates

10-Day MA	$5.31
50-Day MA	$4.98
200-Day MA	$4.57

See more pivots

Amneal Pharmaceuticals, Inc. Stock, NYSE:AMRX

400 Crossing Boulevard, 3rd floor, Bridgewater, New Jersey 08807

United States of America

Phone: +1.908.947.3120

Number of Employees: 5500

http://www.amneal.com

Description

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.